Marker Therapeutics Share Price Today
(NASDAQ: MRKR)

Name: Marker Therapeutics Share Price Today (NASDAQ: MRKR) - Marker Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Marker Therapeutics share price is $1.55 & ₹134.57 as on 12 Feb 2025, 2.30 'hrs' IST

$1.55

▲

-0.17

(-9.88%)

Market is closed - opens 8 PM, 12 Feb 2025

View live Marker Therapeutics share price in Dollar and Rupees. Guide to invest in Marker Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Marker Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Marker Therapeutics share price movements

Today's Low: $1.55
Today's High: $1.88
$1.55
0.21%
Downside
Day's Volatility :17.73%
Upside
17.55%
52 Weeks Low: $1.55
52 Weeks High: $5.99
$1.55
0.0%
Downside
52 Weeks Volatility :74.12%
Upside
74.12%

Marker Therapeutics (MRKR) Returns

Period	Marker Therapeutics Inc	Index (Russel 2000)
3 Months	-52.75%	0.0%
6 Months	-48.84%	0.0%
1 Year	-58.8%	0.0%
3 Years	-69.29%	-12.9%

Marker Therapeutics (MRKR) Key Statistics

in dollars & INR

Previous Close	$1.72
Open	$1.85
Today's High	$1.88
Today's Low	$1.5467
Market Capitalization	$19.0M
Today's Volume	$62.5K
52 Week High	$5.99
52 Week Low	$1.5467
Revenue TTM	$3.7M
EBITDA	$-11.8M
Earnings Per Share (EPS)	$-1.04
Profit Margin	-278.22%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-71.74%

How to invest in Marker Therapeutics Stock (MRKR) from India?

It is very easy for Indian residents to invest directly in Marker Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Marker Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Marker Therapeutics or MRKR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Marker Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Marker Therapeutics shares which would translate to 0.560 fractional shares of Marker Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Marker Therapeutics, in just a few clicks!

Returns in Marker Therapeutics (MRKR) for Indian investors in Rupees

The Marker Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Marker Therapeutics investment value today

Current value as on today

₹41,703

Returns

₹58,297

(-58.3%)

Returns from Marker Therapeutics Stock

₹62,919 (-62.92%)

Dollar Returns

₹4,622 (+4.62%)

Indian investors sentiment towards Marker Therapeutics (MRKR)

-22%

Period: Jan 12, 2025 to Feb 11, 2025. Change in 30 Days versus previous period

Search interest for Marker Therapeutics Stock from India on INDmoney has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Marker Therapeutics

NEA Management Company, LLC
10.00%
Aisling Capital Management LP
2.93%
Vanguard Group Inc
2.27%
Geode Capital Management, LLC
0.67%
Renaissance Technologies Corp
0.37%
Northern Trust Corp
0.30%

Analyst Recommendation on Marker Therapeutics

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Marker Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Marker Therapeutics Stock (MRKR)

What analysts predicted

Upside of 1125.81%

Target:

$19.00

Current:

$1.55

Insights on Marker Therapeutics Stock (Ticker Symbol: MRKR)

Price Movement
In the last 7 days, MRKR stock has moved down by -8.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 1.16M → 1.92M (in $), with an average increase of 39.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -2.19M → -2.30M (in $), with an average decrease of 5.3% per quarter
MRKR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.2% return, outperforming this stock by 120.6%
MRKR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 81.8% return, outperforming this stock by 151.1%
Price to Sales
ForMRKR every $1 of sales, investors are willing to pay $4.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.6 for every $1 of sales.

Marker Therapeutics Technicals Summary

Sell

Neutral

Buy

Marker Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Marker Therapeutics (MRKR) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Marker Therapeutics Inc	-37.11%	-48.84%	-58.8%	-69.29%	-93.7%
Biontech Se	1.35%	35.85%	27.26%	-25.41%	274.86%
Regeneron Pharmaceuticals, Inc.	-3.7%	-40.32%	-26.59%	10.72%	72.78%
Vertex Pharmaceuticals Incorporated	13.69%	-0.31%	12.96%	103.25%	92.75%
Alnylam Pharmaceuticals, Inc.	6.11%	4.25%	69.17%	84.35%	112.94%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Marker Therapeutics Inc	NA	NA	NA	-1.05	-0.72	-0.41	NA	1.58
Biontech Se	160.8	NA	0.04	-3.29	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	18.52	18.52	1.04	43.84	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	18.76	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Marker Therapeutics Inc	Buy	$19.0M	-93.7%	NA	-278.22%
Biontech Se	Buy	$27.6B	274.86%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$77.6B	72.78%	18.52	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$121.0B	92.75%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.3B	112.94%	NA	-15.86%

About Marker Therapeutics

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

Organization	Marker Therapeutics
Employees	8
CEO	Dr. Juan F. Vera M.D.
Industry	Consumer Services

Management People of Marker Therapeutics

Name	Title
Dr. Juan F. Vera M.D.	Co-Founder, CEO, President, Treasurer, Secretary & Director
Ms. Elizabeth Donnelly	Director of Administration
Dr. Maria-Bernadette Madel	Director of Corporate Operations & External Communications
Mr. Edmund Cheung	Vice President of Human Resources
Dr. Monic Stuart M.D.	Chief Medical Officer
Patricia Allison	Head of Clinical Operations
Ms. Mary Newman Ph.D.	Head of Regulatory Affairs
Dr. Robert Z. Florkiewicz Sr.	Senior Director of Molecular Biology & Virology

Important FAQs about investing in MRKR Stock from India :

What is Marker Therapeutics share price today?

Marker Therapeutics share price today stands at $1.55, Open: $1.85 ; Previous Close: $1.72 ; High: $1.88 ; Low: $1.55 ; 52 Week High: $5.99 ; 52 Week Low: $1.55.

The stock opens at $1.85, after a previous close of $1.72. The stock reached a daily high of $1.88 and a low of $1.55, with a 52-week high of $5.99 and a 52-week low of $1.55.

Can Indians buy Marker Therapeutics shares?

Yes, Indians can invest in the Marker Therapeutics (MRKR) from India.

With INDmoney, you can buy Marker Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Marker Therapeutics at zero transaction cost.

How can I buy Marker Therapeutics shares from India?

It is very easy to buy Marker Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Marker Therapeutics (MRKR) be purchased?

Yes, you can buy fractional shares of Marker Therapeutics with INDmoney app.

What are the documents required to start investing in Marker Therapeutics stocks?

To start investing in Marker Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.